FDA commissioner spells out agency's top priorities, with a focus on dispelling misinformation
It’s been a little more than six months since FDA commissioner Rob Califf won Senate confirmation, and while he highlighted some of his key goals early on, he offered the agency’s latest array of top priorities in a JAMA viewpoint yesterday afternoon.
At the top of the list, even as general fatigue has taken hold among the public’s perception toward the pandemic, is Covid-19, and the ongoing opioid addiction crisis, which took more than 100,000 lives in 2021.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.